"I love Shanghai Medicilon Inc. - Preclinical Research_Drug Selection_Drug Safety Evaluation_Pharmacokinetic Service_Shanghai Biology|CRO"

2022-05-07 04:55:52

Stock Code 688202 346.98 PM 16:47•2022-05-07 ABOUT SERVICES PLATFORM CLIENT CENTER | ABOUT SERVICES PLATFORM CLIENT CENTER NEWS INVESTORS CAREERS | ABOUT Company Profile Management Team Message from the CEO Corporate Culture Company History Honors and Awards Over 18 years of experience in R&D Learn more 01Drug Discovery Chemistry Research Medicinal Chemistry Synthetic Chemistry Analytical Chemistry Biology Research Structural Biology Cell Biology Computational Biology & Molecular Modeling Enzymology & Molecular Interactions Early Pharmacokinetics 02Pharmaceutical Research Intermediates APIs Route Selection Production Process Optimization Clinical Sample Production Impurity Traceability & Control Generic Drug Process Study & Filing Innovative Drug Process Study & Filing Pharmaceutic Preparation Preformulation Study Formulation Technology Research Preparation Quality Research Laboratory-scale Preparation Testing Pilot-scale Preparation Testing GMP-based Clinical Sample Production & Packaging Formulation Stability Study Consistency Evaluation Analytical Method Development & Quality Control CMC Filings 03Preclinical Research Pharmacology & Pharmacodynamics Tumor Models Digestive System Disease Models Endocrine & Metabolic Disease Models Inflammatory & Immune Diseases Models Neural System Disease Models Other Disease Models Drug Safety Evaluation Pharmacology & Toxicology Study Safety Pharmacology Histopathological Study Clinicopathological Study Drug Safety Evaluation Basic Information Toxicokinetics Pharmacokinetics In Vitro Pharmacokinetic Assays In Vivo Pharmacokinetic Assays Bioanalysis Macromolecular Drugs Bioanalysis Micromolecular Drugs Bioanalysis IND Filings 01One-stop Integrated Services Pharmaceutical Research CDMO Service Platform Chemical Drug Development Medicilon’s CDMO Service Platform Preclinical Research Services 02Key Technical Services for Drug R&D Process Department Solid Form Screening Platform SEND Format Conversion Platform Medicilon Flow Cytometry Technology Platform Safety Assessment Lab of Process Chemistry Drug Forming Research Platform MetID Service Platform Cytokine and Biomarker Detection Platform 03Innovative Drug SERVICES Non-clinical Research for Cellular Immunotherapies mRNA Vaccine Bioanalysis Platform PROTAC Drug Discovery Research Platform Antibody-Drug Conjugate(ADC) 04Drug Efficacy Evaluation for Common Diseases Pharmacodynamic Evaluation Model Platform for Inflammatory and Immune Diseases IO Pharmacodynamic Model Evaluation Platform 05Advanced Preparation R&D Skin Topical Preparation R&D Ophthalmic drug R&D platform Inhalation drug R&D platform 06Drug Analysis 07Public Services Video of Medicilon Preclinical Research CLIENT CENTER Intellectual Property Protection Downloads Partnerships Newsletters Global U.S. Address: 1 Broadway, Cambridge, MA02142 (America) Tel: +1(626)986-9880 UK Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK Tel: 0044 7790 816 954 Email: [email protected] China Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters) Postcode: 201299 Tel: +86 (21) 5859-1500 (main line) Fax: +86 (21) 5859-6369 News Medicilon Events Featured Stories Market Events Videos 2022-05-07 Featured Stories Overview of the Drug Discovery Process The steps of drug discovery can be simply summarized as disease→target→hit→lead→candidate→drug. Learn more 2022-05-05 Medicilon Events Medicilon Assists - The first China-made targeting folic acid receptor FRα ADC injection BAT8006 was approved for clinical use Recently, Bio-Thera Solutions, Ltd. (Bio-Thera) has been approved for clinical application of BAT8006 for injection. Learn more INVESTORS Stock Information Investment Contact Medicilon 688202 346.98 RMB -1.25 （ -0.36 %） As of 2022-05-07 16:47 Beijing time The data is from a third-party organization and is only for reference. For actual information, please refer to：www.eastmoney.com CAREERS Talent Development Employee Activities Campus Recruitment Social Recruitment Campus Recruitment Campus Recruitment Social Recruitment Social Recruitment © 2021 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3 Shanghai Public Network Security File No. 31011502018888|Website Map Close ABOUT Company Profile Management Team Honors and Awards Corporate Culture SERVICES Drug Discovery Pharmaceutical Research Preclinical Research PLATFORM One-stop Integrated Services Key Technical Services for Drug R&D Innovative Drug R&D Services Drug Efficacy Evaluation for Common Diseases Advanced Preparation R&D CLIENT CENTER Intellectual Property Protection Downloads Partnerships Newsletters NEWS Medicilon Events Featured Stories Market Events Videos INVESTORS Stock Information Investment Contact CAREERS Talent Development Employee Activities Campus Recruitment Social Recruitment © 2021 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3 Shanghai Public Network Security File No. 31011502018888|Website Map Close CN Home ABOUT ABOUT Company Profile Management Team Honors and Awards Corporate Culture SERVICES Drug Discovery Chemistry Research Biology Research Early Pharmacokinetics Pharmaceutical Research Intermediates APIs Pharmaceutic Preparation Analytical Method Development & Quality Control CMC Filings Preclinical research Pharmacology & Pharmacodynamics Drug Safety Evaluation Pharmacokinetics Bioanalysis IND Filings PLATFORM One-stop Integrated Services Key Technical Services for Drug R&D Innovative Drug R&D Services Drug Efficacy Evaluation for Common Diseases Advanced Preparation R&D Public Services CLIENT CENTER Intellectual Property Protection Downloads Partnerships Newsletters NEWS Medicilon Events Featured Stories Market Events Videos INVESTORS Stock Information Investment Contact CAREERS Talent Development Employee Activities Campus Recruitment Social Recruitment Business Inquiry Global： Email:[email protected] +1(626)986-9880(U.S. - West Coast) 0044 7790 816 954 (Europe) China： Email: [email protected] Tel: +86 (21) 5859-1500 Online Message× MEDICILON DRIVEN BY INNOVATION, QUALITY FIRST Reliable CRO with integrated preclinical R&D Learn more MEDICILON PROFESSIONAL EXPERTISE POWERING R&D Strict quality inspections for superior drug development Learn more MEDICILON EFFICIENT MANAGEMENT DELIVERS WIN-WIN COLLABORATION Efficient processes that accelerate new drug R&D Learn more MEDICILON WE FORGE FORWARD, DRIVEN BY OUR UNYIELDING EFFORTS Great career to head to new drug R&D Learn more Official promo Services Preclinical Research Learn more Platform Solid Form Screening Learn more MEDICILON DRIVEN BY INNOVATION, QUALITY FIRST Reliable CRO with integrated preclinical R&D MEDICILON PROFESSIONAL EXPERTISE POWERING R&D Strict quality inspections for superior drug development MEDICILON EFFICIENT MANAGEMENT DELIVERS WIN-WIN COLLABORATION Efficient processes that accelerate new drug R&D MEDICILON WE FORGE FORWARD, DRIVEN BY OUR UNYIELDING EFFORTS Great career to head to new drug R&D about medicilon From drug discovery to IND filings We aim to accelerate R&D through higher efficiency and lower costs Medicilon is committed to providing integrated preclinical research for pharmaceutical enterprises, research institutions, and scientific researchers around the world, and promoting new drug research as a preclinical R&D outsourcing service provider. Learn more 2022-05-05Medicilon Events Lockdown Never Stopped; Resumption of Work Increases Efficiency On the evening of March 27, right before the lockdown, Medicilon immediately launched the emergency plan in order to maintain the regular R&D work. Learn more 2022-04-27Medicilon Events Medicilon was awarded the "Top Ten Drug Innovation Service Organizations of the Year" in the 2021 Drug Innovation Award On April 20th, the 2021 Drug Innovation Award sponsored by Securities Times, Medicilon was awarded the "Top Ten Drug Innovation Service Organizations of the Year" in the 2021 Drug Innovation Award. Learn more 2022-04-19Medicilon Events Medicilon Appoints Dr. Christopher Stewart, DABT as Senior Scientific Advisor Shanghai Medicilon Inc. announced the appointment of Dr. Christopher Stewart, DABT as the Senior Scientific Advisor of Medicilon. Learn more 2022-04-19Medicilon Events Lockdown But Not Stop - Medicilon Researchers Continue to Fight Medicilon is deeply aware of its responsibilities toemployees, pharmaceutical companies and scientific research institutions, and even for the entire biopharmaceutical industry chain as an integrated prclinial R&D facility. Learn more 2022-04-13Market Events Join Medicilon at BioTrinity 2022: Catalysing Growth in the Life Sciences Industry BioTrinity 2022 is only a couple weeks away! Medicilon is excited to attend and exhibit at the conference. Our Vice President and Business Development team will be exhibiting at the conference. Learn more 2022-03-24Market Events Join Medicilon at ELRIG Research & Innovation 2022 – for tomorrow's drug discovery Medicilon welcomes you to join us at ELRIG RESEARCH & INNOVATION 2022. Learn more 2022-03-02Market Events Join Medicilon at AACR Annual Meeting 2022 Medicilon is excited to announce we will be exhibiting at AACR Annual Meeting 2022. Our US team Dr. Stephen Grant and Dr. Yang Wang will be hosting the booth at the conference (booth 3224). Learn more 2022-02-18Medicilon Events Medicilon Appoints Dr. Zhenrong Guo as Executive Vice President of Pharmacy Recently, Shanghai Medicilon Inc. (stock code: 688202.SH) (Medicilon) announced the appointment of Dr. Zhenrong Guo as the Executive Vice President of Pharmacy (APIs + Preparations). Learn more 2022-02-09Market Events Join Medicilon at 2022 SOT Annual Meeting ​Medicilon is excited to exhibit at the 2022 SOT Annual Meeting. Our Vice President, Dr. Mingzhu Zhang, and Director of US BD, Yang Wang will be hosting the booth in the conference. Learn more 2022-01-24Medicilon Events Medicilon Assisted DAC Biotechnology's Fourth ADC Drug DXC007 Getting Approved for Clinical Use On December 28, 2021, Hangzhou DAC Biotechnology Co., Ltd. (DAC Biotech) DXC007 project was successfully approved for clinical trials. DXC007 is the fourth ADC drug approved for clinical use by DAC Biotech, and it is also the fourth ADC drug that Shanghai Medicilon Inc. (Medicilon) to help DAC Biotech successfully getting approval. Learn more 2022-05-05Medicilon Events Lockdown Never Stopped; Resumption of Work Increases Efficiency On the evening of March 27, right before the lockdown, Medicilon immediately launched the emergency plan in order to maintain the regular R&D work. Learn more 2022-04-27Medicilon Events Medicilon was awarded the "Top Ten Drug Innovation Service Organizations of the Year" in the 2021 Drug Innovation Award On April 20th, the 2021 Drug Innovation Award sponsored by Securities Times, Medicilon was awarded the "Top Ten Drug Innovation Service Organizations of the Year" in the 2021 Drug Innovation Award. Learn more 2022-04-19Medicilon Events Medicilon Appoints Dr. Christopher Stewart, DABT as Senior Scientific Advisor Shanghai Medicilon Inc. announced the appointment of Dr. Christopher Stewart, DABT as the Senior Scientific Advisor of Medicilon. Learn more 2022-04-19Medicilon Events Lockdown But Not Stop - Medicilon Researchers Continue to Fight Medicilon is deeply aware of its responsibilities toemployees, pharmaceutical companies and scientific research institutions, and even for the entire biopharmaceutical industry chain as an integrated prclinial R&D facility. Learn more 2022-04-13Market Events Join Medicilon at BioTrinity 2022: Catalysing Growth in the Life Sciences Industry BioTrinity 2022 is only a couple weeks away! Medicilon is excited to attend and exhibit at the conference. Our Vice President and Business Development team will be exhibiting at the conference. Learn more 2022-03-24Market Events Join Medicilon at ELRIG Research & Innovation 2022 – for tomorrow's drug discovery Medicilon welcomes you to join us at ELRIG RESEARCH & INNOVATION 2022. Learn more 2022-03-02Market Events Join Medicilon at AACR Annual Meeting 2022 Medicilon is excited to announce we will be exhibiting at AACR Annual Meeting 2022. Our US team Dr. Stephen Grant and Dr. Yang Wang will be hosting the booth at the conference (booth 3224). Learn more 2022-02-18Medicilon Events Medicilon Appoints Dr. Zhenrong Guo as Executive Vice President of Pharmacy Recently, Shanghai Medicilon Inc. (stock code: 688202.SH) (Medicilon) announced the appointment of Dr. Zhenrong Guo as the Executive Vice President of Pharmacy (APIs + Preparations). Learn more 2022-02-09Market Events Join Medicilon at 2022 SOT Annual Meeting ​Medicilon is excited to exhibit at the 2022 SOT Annual Meeting. Our Vice President, Dr. Mingzhu Zhang, and Director of US BD, Yang Wang will be hosting the booth in the conference. Learn more 2022-01-24Medicilon Events Medicilon Assisted DAC Biotechnology's Fourth ADC Drug DXC007 Getting Approved for Clinical Use On December 28, 2021, Hangzhou DAC Biotechnology Co., Ltd. (DAC Biotech) DXC007 project was successfully approved for clinical trials. DXC007 is the fourth ADC drug approved for clinical use by DAC Biotech, and it is also the fourth ADC drug that Shanghai Medicilon Inc. (Medicilon) to help DAC Biotech successfully getting approval. Learn more 01 Drug Discovery 02 Pharmaceutical Research 03 Preclinical Research One-stop preclinical pharmaceutical R&D outsourcing service Discover breakthrough drugs with our scientific knowledge and expertise Drug Discovery Analytical ChemistrySynthetic ChemistryMedicinal ChemistryStructural BiologyCell BiologyEarly Pharmacokinetics Learn more One-stop preclinical pharmaceutical R&D outsourcing service We coordinate the entire new drug R&D process, comprehensively optimizing the cost, schedule and quality Pharmaceutical Research IntermediatesCMC FilingsRoute ScreeningClinical Sample ProductionPreformulation StudyFormulation Technology ResearchConsistency EvaluationPilot-scale Preparation Testing Learn more One-stop preclinical pharmaceutical R&D outsourcing service With our global vision and dedication to excellence, we have gained particular insights into the clinical manifestation of drugs Preclinical research Tumor-ModelsDigestive System DiseasesDrug Safety EvaluationSafety PharmacologyToxicokineticsPharmacokineticsBioanalysisIND Filings Learn more One-stop preclinical pharmaceutical R&D outsourcing service Discover breakthrough drugs with our scientific knowledge and expertise Drug Discovery Analytical ChemistrySynthetic ChemistryMedicinal ChemistryStructural BiologyCell BiologyEarly Pharmacokinetics Learn more One-stop preclinical pharmaceutical R&D outsourcing service We coordinate the entire new drug R&D process, comprehensively optimizing the cost, schedule and quality Pharmaceutical Research IntermediatesCMC FilingsRoute ScreeningClinical Sample ProductionPreformulation StudyFormulation Technology ResearchConsistency EvaluationPilot-scale Preparation Testing Learn more One-stop preclinical pharmaceutical R&D outsourcing service With our global vision and dedication to excellence, we have gained particular insights into the clinical manifestation of drugs Preclinical research Tumor-ModelsDigestive System DiseasesBioanalysisDrug Safety EvaluationSafety PharmacologyIND FilingsToxicokineticsPharmacokinetics Learn more Strive for the unfinished business of human health Faster, better, and stronger, Medicilon is always on its way Join Us Work with us to become better Learn more Corporate Culture We strive to provide all-round preclinical R&D services for innovative drug researchers around the world Learn more Honors and Awards Each honor we have earned powers us further forward Learn more Join Us Corporate Culture Honors and Awards Stock Code 688202 346.98 PM 16:47•2022-05-07 Global Address: 1 Broadway, Cambridge, MA02142 (America) Tel: +1(626)986-9880(U.S. - West Coast) Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK Tel: 0044 7790 816 954 (Europe) Email: [email protected] China Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters) Postcode: 201299 Tel: +86 (21) 5859-1500 (main line) Fax: +86 (21) 5859-6369 © 2021 © 2021 Shanghai Medicilon Inc. All rights reserved | All Rights Reserved Privacy Policy Website Map bioanalytical testing IND Filing PROTAC API ADME Drug Discovery Animal Models Oral Solid Dosage PDX model Pharmacokinetics More